Evidence map›Paper›PMID 37171590›Full record

ArticleGlycobiology2023

Computational studies on glycosaminoglycan recognition of sialyl transferases.

Nehru Viji Sankaranarayanan, Srinivas Sistla, Balaji Nagarajan, John E Chittum, Joseph T Y Lau, Umesh R Desai

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nehru Viji SankaranarayananDepartment of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.ORCID 0000-0002-2870-9164
Srinivas SistlaDepartment of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.
Balaji NagarajanDepartment of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.ORCID 0000-0003-3892-6178
John E ChittumDepartment of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.ORCID 0000-0002-6094-7373
Joseph T Y LauDepartment of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo 14263, NY, USA.ORCID 0000-0002-5128-2664
Umesh R DesaiDepartment of Medicinal Chemistry, Virginia Commonwealth University, Virginia 23298, Richmond, USA.ORCID 0000-0002-1976-6597
Virginia Commonwealth University · USRoswell Park Comprehensive Cancer Center · US

Funding

Project 3: Role of Glycosaminoglycans in HematopoiesisP01HL151333 · NHLBI · VERSITI WISCONSIN, INC. · PI DESAI, UMESH RAMANLAL · 2021 to 2025
$12.3M
Glycans in Blood Homeostasis and DiseaseK12HL141954 · NHLBI · VERSITI WISCONSIN, INC. · PI DAHMS, NANCY M., DESAI, UMESH RAMANLAL · 2018 to 2022
$4.9M
ST6Gal-1 Sialyltransferase in InflammationR01AI140736 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI LAU, JOSEPH TY · 2018 to 2021
$3.9M
Tool for Predicting Glycosaminoglycan Recognition of ProteinsU01CA241951 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2019 to 2021
$991k
High Performance Computing Cluster for Biomedical Research at VCUS10RR027411 · NCRR · VIRGINIA COMMONWEALTH UNIVERSITY · PI CUI, MENG · 2010 to 2010
$417k
NCI NIH HHS U01 CA241951NCRR NIH HHS S10 RR027411NHLBI NIH HHS K12 HL141954NHLBI NIH HHS P01 HL151333NIAID NIH HHS R01 AI140736
6 · The paper itself

Abstract

Despite decades of research, glycosaminoglycans (GAGs) have not been known to interact with sialyl transferases (STs). Using our in-house combinatorial virtual library screening (CVLS) technology, we studied seven human isoforms, including ST6GAL1, ST6GAL2, ST3GAL1, ST3GAL3, ST3GAL4, ST3GAL5, and ST3GAL6, and predicted that GAGs, especially heparan sulfate (HS), are likely to differentially bind to STs. Exhaustive CVLS and molecular dynamics studies suggested that the common hexasaccharide sequence of HS preferentially recognized ST6GAL1 in a site overlapping the binding site of the donor substrate CMP-Sia. Interestingly, CVLS did not ascribe any special role for the rare 3-O-sulfate modification of HS in ST6GAL1 recognition. The computational predictions were tested using spectrofluorimetric studies, which confirmed preferential recognition of HS over other GAGs. A classic chain length-dependent binding of GAGs to ST6GAL1 was observed with polymeric HS displaying a tight affinity of ~65 nM. Biophysical studies also confirmed a direct competition between CMP-Sia and an HS oligosaccharide and CS polysaccharide for binding to ST6GAL1. Overall, our novel observation that GAGs bind to ST6GAL1 with high affinity and compete with the donor substrate is likely to be important because modulation of sialylation of glycan substrates on cells has considerable physiological/pathological consequences. Our work also brings forth the possibility of developing GAG-based chemical probes of ST6GAL1.

Indexed as

GlycosaminoglycansTransferasesBinding SitesHeparan SulfateHumansMolecular Dynamics SimulationGlycosaminoglycansHeparan SulfateTransferasescompetitive bindingcomputational modelingglycosaminoglycansheparan sulfatesialyl transferases

Identifiers

PMID37171590
PMCPMC10426320
OpenAlexW4376224196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.